This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jan;67(1):450-451.

doi: 10.1002/hep.29555.

Reply

Aijaz Ahmed¹, Rachel Beckerman², Zobair M Younossi³

Affiliations

Affiliations

¹ Stanford University School of Medicine, Stanford, CA.
² Maple Health Group, LLC, New York, NY.
³ Inova Fairfax Hospital, Falls Church, VA.

PMID: 28960407
DOI: 10.1002/hep.29555

Comment

Reply

Aijaz Ahmed et al. Hepatology. 2018 Jan.

. 2018 Jan;67(1):450-451.

doi: 10.1002/hep.29555.

Authors

Aijaz Ahmed¹, Rachel Beckerman², Zobair M Younossi³

Affiliations

¹ Stanford University School of Medicine, Stanford, CA.
² Maple Health Group, LLC, New York, NY.
³ Inova Fairfax Hospital, Falls Church, VA.

PMID: 28960407
DOI: 10.1002/hep.29555

No abstract available

PubMed Disclaimer

Comment on

Treatment of patients waitlisted for liver transplant with all-oral direct-acting antivirals is a cost-effective treatment strategy in the United States.
Ahmed A, Gonzalez SA, Cholankeril G, Perumpail RB, McGinnis J, Saab S, Beckerman R, Younossi ZM. Ahmed A, et al. Hepatology. 2017 Jul;66(1):46-56. doi: 10.1002/hep.29137. Epub 2017 May 27. Hepatology. 2017. PMID: 28257591
Societal perspectives analysis for evaluating direct-acting antiviral affordability while awaiting liver transplant.
Liu X, Elmofti Y, Kulaga C, Gisi B, Yoo JW. Liu X, et al. Hepatology. 2018 Jan;67(1):450. doi: 10.1002/hep.29558. Hepatology. 2018. PMID: 28960417 No abstract available.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations